MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis-Reference-Cited by-同舟云学术

MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis

Published:2019-07-03 Issue:7 Volume:19 Page:721-733
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

van Loo Pieter Fokko¹,Hangalapura Basav N.²,Thordardottir Soley²,Gibbins John D.²,Veninga Henrike¹,Hendriks Linda J. A.¹,Kramer Arjen¹,Roovers Rob C.¹^ORCID,Leenders Marij²,de Kruif John¹,Doornbos Robert P.¹,Sirulnik Andres¹,Throsby Mark¹,Logtenberg Ton¹,Dolstra Harry²^ORCID,Bakker Alexander B. H.¹

Affiliation:

1. Merus N.V., Utrecht, The Netherlands

2. Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

Funder

Merus N.V

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://tandfonline.com/doi/pdf/10.1080/14712598.2019.1623200

Reference48 articles.

1. TNF-α induces the generation of Langerin/(CD207)+ immature Langerhans-type dendritic cells from both CD14CD1a and CD14+CD1a precursors derived from CD34+ cord blood cells

2. High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

3. Therapeutic Advances in Acute Myeloid Leukemia